Evidence map›Paper›PMID 26099275›Full record

ReviewBMC infectious diseases2015

Infectious endocarditis caused by Helcococcus kunzii in a vascular patient: a case report and literature review.

Romain Lotte, Laurène Lotte, Nicolas Degand, Alice Gaudart, Sylvie Gabriel, Mouna Ben H'dech, Mathilde Blois, Jean-Paul Rinaldi, Raymond Ruimy

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. BMJ case reports · 2021
    Article
  6. Article
  7. BMJ case reports · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Romain LotteDepartment of Bacteriology at Nice Academic Hospital, Nice, France. lotte.r@chu-nice.fr.
Laurène LotteDepartment of Bacteriology at Nice Academic Hospital, Nice, France. lotte.l@chu-nice.fr.
Nicolas DegandDepartment of Bacteriology at Nice Academic Hospital, Nice, France. degand.n@chu-nice.fr.
Alice GaudartDepartment of Bacteriology at Nice Academic Hospital, Nice, France. gaudart.a@chu-nice.fr.
Sylvie GabrielDepartment of Medical Biology, Monaco Princess Grace General Hospital, Monaco, Monaco. sgabriel@chpg.mc.
Mouna Ben H'dechDepartment of Cardiology, Monaco Princess Grace General Hospital, Monaco, Monaco. mona_lisa_69@hotmail.fr.
Mathilde BloisDepartment of Bacteriology at Nice Academic Hospital, Nice, France. blois.m@chu-nice.fr.
Jean-Paul RinaldiDepartment of Cardiology, Monaco Princess Grace General Hospital, Monaco, Monaco. jrinaldi@chpg.mc.
Raymond RuimyDepartment of Bacteriology at Nice Academic Hospital, Nice, France. ruimy.r@chu-nice.fr.
Centre Hospitalier Universitaire de Nice · FRPrincess Grace Hospital Centre · MCUniversité Côte d'Azur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHelcococcus kunzii is a facultative anaerobic bacterium that was first described by Collins et al. in 1993, and was initially considered as a commensal of the human skin, in particular of lower extremities. Human infections caused by H. kunzii remain rare with only a few cases published in the pubmed database. Nevertheless recent reports indicate that this microorganism has to be considered as an opportunistic pathogen that can be involved in severe infections in human. To the best of our knowledge, we describe here the first known case of infectious endocarditis caused by H. kunzii. CASE PRESENTATION: A 79 year-old man reporting severe polyvascular medical history attended the emergency ward for rapid deterioration of his general state of health. After physical examination and paraclinical investigations, the diagnosis of infectious endocarditis on native mitral valve caused by Helcococcus kunzii was established based on Dukes criteria. MALDI-TOF mass spectrometry and 16S rDNA sequencing allowed an accurate identification to the species level of Helcococcus kunzii. The patient was successfully treated by a medico-surgical approach. The treatment consisted in intravenous amoxicillin during four weeks and mitral valve replacement with a bioprosthestic valve. After an in depth review of patient's medical file, the origin of infection remained unknown. However, a cutaneous portal of entry cannot be excluded as the patient and his General Practitioner reported chronic ulcerations of both feet.

conclusionsWe describe here the first case of endocarditis caused by H. kunzii in an elderly patient with polyvascular disease. This report along with previous data found in the literature emphasizes the invasive potential of this bacterial species as an opportunistic pathogen, in particular for patient with polyvascular diseases. MALDI-TOF mass spectrometry and 16S rDNA sequencing are reliable tools for H. kunzii identification. We also sequenced in this work H.kunzii type strain 103932T CIP and deposited in the Genbank under accession number KM403387. We noticed a 14 base difference between our sequence and the original sequence deposited by Collins et al. under Genbank accession number X69837. Hopefully, the spread of next generation sequencing tools would lead to a more accurate classification of clinical strains.

Indexed as

Mitral ValveAgedAortic Aneurysm, AbdominalCarotid Artery DiseasesDNA, RibosomalEndocarditis, BacterialFoot UlcerGram-Positive Bacterial InfectionsHigh-Throughput Nucleotide SequencingHumansMaleMyocardial IschemiaPeptostreptococcusSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationDNA, Ribosomal

Identifiers

PMID26099275
PMCPMC4477501
OpenAlexW2100097992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.